A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study
Start Date
12/21/2023
Completion Date
5/1/2026
Summary
The ON-SITE study represents a prospective, observational study focused on the training/tuning and pivotal validation of deep learning algorithms that detect cell/tissue morphology suspicious for cancer in biopsies of peripheral lung nodules/masses and mediastinal/hilar lymph nodes imaged with the NIO Laser Imaging System in the procedure room without requiring traditional sample processing. The study includes four arms based on biopsy location and biopsy modality/tool: 1. Transbronchial forceps biopsy of peripheral lung nodules/masses (peripheral-TBBx) 2. Transbronchial needle aspiration biopsy of peripheral lung nodules/masses (peripheral TBNA) 3. Transbronchial needle aspiration biopsy of mediastinal/hilar lymph nodes (EBUS-TBNA) 4. Transbronchial cryo biopsy of peripheral lung nodules/masses (peripheral-CBx)
Eligibility Criteria
Age Range: 22 years to No maximum
Conditions
Locations
UC San Diego
San Diego, California 92037
United States
Mayo Clinic Jacksonville
Jacksonville, Florida 32224
United States
Corewell Health
Grand Rapids, Michigan 49503
United States
Memorial Sloan Kettering Cancer Center
New York, New York 10065
United States
Montefiore Medical Center
The Bronx, New York 10467
United States
UNC Medical Center
Chapel Hill, North Carolina 27514
United States
MD Anderson Cancer Center
Houston, Texas 77030
United States